Study to Evaluate the Safety and Immunogenicity of Investigational Vaccines Using the RSV (Respiratory Syncytial Virus) Monovalent Antigen in Healthy Participants 18 to 49 Years of Age
PHASE1
The purpose of this study is to evaluate the safety and immunogenicity of d...
A Dose Escalation Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1345 in Healthy Adults and in Children Who Are Respiratory Syncytial Virus (RSV)-Seropositive
PHASE1
The primary objectives of this study are to evaluate the tolerability and r...
Status
Completed
Location
Paradigm Clinical Research Institute Inc - ClinEdge - PPDS
A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Parainfluenza Vaccines in Adults 18 to 49 Years of Age.
PHASE1
The objective of this study is to evaluate the safety and immunogenicity of...